Gyre Therapeutics, Inc. Comparables

Find the most relevant public market comparables for Gyre Therapeutics, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.

Company Overview

A commercial-stage biopharmaceutical company focused on the research, development, manufacturing, and commercialization of drugs for organ fibrosis. They develop and commercialize small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, specifically organ fibrosis. The company has commercial-stage products and a diverse pipeline of drug candidates, operating in both the US and China.

Business Model

Research, development, manufacturing, and commercialization of drugs for organ fibrosis.

Target Customers

Patients with organ fibrosis, including those with NASH-associated fibrosis, CHB-associated liver fibrosis, IPF, SSc-ILD, PF-ILD, CLD-associated thrombocytopenia, and chronic idiopathic thrombocytopenia.

Specific Focus

Organ fibrosis treatment

Location

San Diego, California

CEO

Han Ying, Ph.D.

Industry

Life sciences

Sub Sector

Biotechnology

3yr Revenue Growth

442%

Website

gyretx.com

Public Market Comparables

Below are the key valuation metrics for companies similar to Gyre Therapeutics, Inc. in the Pharmaceuticals & Biotech sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.

Looking for a comprehensive compset for Gyre Therapeutics, Inc.? Our platform provides detailed analysis of Gyre Therapeutics, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Gyre Therapeutics, Inc. compset by trying our platform today.

EV/Revenue Multiple

Min

0.0x

Median

0.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details

EV/EBITDA Multiple

Min

00.0x

Median

00.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details
Screenshot of CompSetFinder showing Gyre Therapeutics, Inc. comps with valuation metrics like EV/Revenue, EV/EBITDA, and P/E

Unlock the Full Gyre Therapeutics, Inc. Compset

As a leading player in the Life sciences industry within the Pharmaceuticals & Biotech sector, Gyre Therapeutics, Inc. operates in the specialized Biotechnology sub-sector. Understanding how Gyre Therapeutics, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.

Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.

Get Your Custom Comparable Analysis

Need a more detailed analysis of Gyre Therapeutics, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.

Try CompsetFinder Free